Antiviral methods and protocols
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Dokumenttyp: | Edited Volume |
| Sprache: | Englisch |
| Veröffentlicht: |
New York [u.a.]
Humana Press
c2013
|
| Ausgabe: | 2. ed. |
| Schriftenreihe: | Methods in molecular biology
1030 |
| In: |
Methods in molecular biology (1030)
|
| Volumes / Articles: | Show Volumes / Articles. |
| Schlagworte: | |
| Online-Zugang: | Verlag, Inhaltsverzeichnis, Inhaltsverzeichnis: http://www.gbv.de/dms/bs/toc/75626426X.pdf Cover: https://swbplus.bsz-bw.de/bsz392312670cov.jpg 
|
| Verfasserangaben: | edited by Edwin Yunhao Gong |
MARC
| LEADER | 00000cam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 75626426X | ||
| 003 | DE-627 | ||
| 005 | 20250709154128.0 | ||
| 007 | tu | ||
| 008 | 130731s2013 xxu||||| 00| ||eng c | ||
| 010 | |a 2013940287 | ||
| 020 | |a 1627034838 |9 1-62703-483-8 | ||
| 020 | |a 9781627034838 |9 978-1-62703-483-8 | ||
| 035 | |a (DE-627)75626426X | ||
| 035 | |a (DE-576)392312670 | ||
| 035 | |a (DE-599)GBV75626426X | ||
| 035 | |a (OCoLC)837136020 | ||
| 035 | |a (OCoLC)858018911 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 044 | |c XD-US |c XA-DE |c XA-NL | ||
| 050 | 0 | |a RM411 | |
| 072 | 7 | |a MMG |2 bicssc | |
| 072 | 7 | |a MED071000 |2 bisacsh | |
| 082 | 0 | |a 615.7/924 |q LOC |2 23 | |
| 084 | |a 33 |2 sdnb | ||
| 084 | |a 30 |2 sdnb | ||
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a VS 8750 |q hdub |2 rvk |0 (DE-625)rvk/147721:253 | ||
| 084 | |a 44.75 |2 bkl | ||
| 084 | |a 44.38 |2 bkl | ||
| 245 | 0 | 0 | |a Antiviral methods and protocols |c edited by Edwin Yunhao Gong |
| 250 | |a 2. ed. | ||
| 264 | 1 | |a New York [u.a.] |b Humana Press |c c2013 | |
| 300 | |a XIV, 452 S. |b Ill., graph. Darst. | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 490 | 1 | |a Methods in molecular biology |v 1030 | |
| 490 | 0 | |a Springer protocols | |
| 500 | |a Literaturangaben | ||
| 505 | 8 | 0 | |t Part IHuman immunodeficiency virus type 1 (HIV-1)Fluorescence-based high-throughput screening assay to identify HIV-1 inhibitors |r Peggy Geluykens ... [et al.] |
| 505 | 8 | 0 | |t Homogeneous time-resolved fluorescence assay to identify inhibitors of HIV-1 fusion |r Liesbet Smeulders ... [et al.] |
| 505 | 8 | 0 | |t Identification of HIV-1 reverse transcriptase inhibitors using a scintillation proximity assay |r Bertrand Van Schoubroeck ... [et al.] |
| 505 | 8 | 0 | |t Biochemical screening assays to identify HIV-1 integrase inhibitors |r Marleen Clynhens ... [et al.] |
| 505 | 8 | 0 | |t HIV-1 genotyping of the protease-reverse transcriptase and integrase genes to detect mutations that confer antiretroviral resistance |r Peter Van den Eede ... [et al.] |
| 505 | 8 | 0 | |t Part IIHepatitis virusesIn vitro kinetic profiling of hepatitis C virus NS3 protease inhibitors by progress curve analysis |r Rumin Zhang and William T. Windsor |
| 505 | 8 | 0 | |t Novel hepatitis C virus NS5B polymerase assay of de novo initiated RNA synthesis directed from a heteropolymeric RNA template |r Eric Ferrari and Hsueh-Cheng Huang |
| 505 | 8 | 0 | |t Selecting and characterizing drug-resistant hepatitis C virus replicon |r Inge Vliegen, Leen Delang, and Johan Neyts |
| 505 | 8 | 0 | |t Cellular replicon-based phenotyping assay to determine susceptibility of hepatitis C virus clinical isolates to NS3/4A protease inhibitors |r Leen Vijgen ... [et al.] |
| 505 | 8 | 0 | |t Expression and purification of hepatitis C virus protease from clinical samples |r Liesbet van der Helm |
| 505 | 8 | 0 | |t Surface plasmon resonance as a tool to select potent drug candidates for hepatitis C virus NS5B polymerase |r Erna Cleiren, Benoit Devogelaere, and Katleen Fierens |
| 505 | 8 | 0 | |t Amplification and sequencing of the hepatitis C virus NS3/4A protease and the NS5B polymerase regions for genotypic resistance detection of clinical isolates of subtypes 1a and 1b |r Diana Koletzki ... [et al.] |
| 505 | 8 | 0 | |t Southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures |r Dawei Cai ... [et al.] |
| 505 | 8 | 0 | |t In vitro phenotyping of recombinant hepatitis B virus containing the polymerase/reverse transcriptase gene from clinical isolates |r Yang Liu and Kathryn M. Kitrinos |
| 505 | 8 | 0 | |t Part IIIFlavivirusesCell-based antiviral assays for screening and profiling inhibitors against dengue virus |r Edwin Yunhao Gong ... [et al.] |
| 505 | 8 | 0 | |t Duplex real-time RT-PCR assay for profiling inhibitors of four dengue serotypes |r Edwin Yunhao Gong ... [et al.] |
| 505 | 8 | 0 | |t High-throughput screening using dengue virus reporter genomes |r Wolfgang Fischl and Ralf Bartenschlager |
| 505 | 8 | 0 | |t Fluorimetric and HPLC-based dengue virus protease assays using a FRET substrate |r Christoph Nitsche and Christian D. Klein |
| 505 | 8 | 0 | |t Expression and purification of dengue virus NS5 polymerase and development of a high-throughput enzymatic assay for screening inhibitors of dengue polymerase |r Edwin Yunhao Gong ... [et al.] |
| 505 | 8 | 0 | |t Detection and quantification of flavivirus NS5 methyl- transferase activities |r Siew Pheng Lim, Christophe Bodenreider, and Pei-Yong Shi |
| 505 | 8 | 0 | |t Testing antiviral compounds in a dengue mouse model |r Wouter Schul, Andy Yip, and Pei-Yong Shi |
| 505 | 8 | 0 | |t Construction of self-replicating subgenomic west nile virus replicons for screening antiviral compounds |r Sofia L. Alcaraz-Estrada, Erin Donohue Reichert, and Radhakrishnan Padmanabhan |
| 505 | 8 | 0 | |t Part IVHerpes virusesMethods for screening and profiling inhibitors of herpes simplex viruses |r Edwin Yunhao Gong |
| 505 | 8 | 0 | |t In vivo evaluation of antiviral efficacy against genital herpes using mouse and guinea pig models |r Frances Valencia, Ronald L. Veselenak, and Nigel Bourne |
| 505 | 8 | 0 | |t Fluorescence-based high-throughput screening assay for identifying human cytomegalovirus inhibitors |r Christel Van den Eynde ... [et al.] |
| 505 | 8 | 0 | |t Part VRespiratory virusesFluorescence-based high-throughput antiviral compound screening assay against respiratory syncytial virus |r Leen Kwanten, Ben De Clerck, and Dirk Roymans |
| 505 | 8 | 0 | |t Screening and evaluation of anti-respiratory syncytial virus compounds in cultured cells |r Anna Lundin, Tomas Bergström, and Edward Trybala |
| 505 | 8 | 0 | |t Evaluation of antiviral efficacy against human respiratory syncytial virus using cotton rat and mouse models |r Joke Van den Berg, Leen Kwanten, and Dirk Roymans |
| 505 | 8 | 0 | |t In vivo evaluation of antiviral compounds on respiratory syncytial virus using a juvenile vervet monkey (Chlorocebus pygerythrus) infection model |r Lieselot Houspie ... [et al.] |
| 505 | 8 | 0 | |t Methods to determine mechanism of action of anti-influenza inhibitors |r Angela Luttick, Stephanie Hamilton, and Simon P. Tucker |
| 505 | 8 | 0 | |t Methods for evaluation of antiviral efficacy against influenza virus infections in animal models |r Donald F. Smee and Dale L. Barnard |
| 505 | 8 | 0 | |t Part VIAlphavirusesDevelopment of a high-throughput antiviral assay for screening inhibitors of chikungunya virus and generation of drug-resistant mutations in cultured cell |r Edwin Yunhao Gong ... [et al.] |
| 505 | 8 | 0 | |t Mouse model of chikungunya virus with utility in antiviral studies |r Ashley Dagley and Justin G. Julander. |
| 583 | 1 | |a Archivierung prüfen |c 20240324 |f DE-4165 |z 1 |2 pdager | |
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |c 20250619 |f SSG |x XA-DE-NI |z SSG Pharmazie |2 pdager |5 DE-84 | |
| 650 | 2 | |a Antiviral Agents | |
| 655 | 7 | |a Aufsatzsammlung |0 (DE-588)4143413-4 |0 (DE-627)105605727 |0 (DE-576)209726091 |2 gnd-content | |
| 689 | 0 | 0 | |d s |0 (DE-588)4063589-2 |0 (DE-627)106127314 |0 (DE-576)209149469 |a Viren |2 gnd |
| 689 | 0 | 1 | |d s |0 (DE-588)4038243-6 |0 (DE-627)104584963 |0 (DE-576)209029218 |a Medizin |2 gnd |
| 689 | 0 | 2 | |d s |0 (DE-588)4039983-7 |0 (DE-627)106225812 |0 (DE-576)209037520 |a Molekularbiologie |2 gnd |
| 689 | 0 | |5 DE-101 | |
| 689 | 1 | 0 | |d s |0 (DE-588)4139555-4 |0 (DE-627)104248289 |0 (DE-576)20969534X |a Viruzid |2 gnd |
| 689 | 1 | |5 (DE-627) | |
| 700 | 1 | |a Gong, Edwin Yunhao |e Hrsg. |4 edt | |
| 776 | 1 | |z 9781627034845 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |t Antiviral methods and protocols |b 2nd ed. 2013 |d Totowa, NJ : Humana Press, 2013 |h Online-Ressource (XIV, 452 p. 52 illus., 28 illus. in color, online resource) |w (DE-627)1652961941 |w (DE-576)392251256 |z 9781627034845 |
| 830 | 0 | |a Methods in molecular biology |v 1030 |9 1030 |w (DE-627)131029002 |w (DE-576)010864504 |w (DE-600)1095346-2 |x 1064-3745 |7 am | |
| 856 | 4 | 2 | |u http://www.gbv.de/dms/bs/toc/75626426X.pdf |m V:DE-601 |m B:DE-84 |q pdf/application |v 2014-09-04 |x Verlag |y Inhaltsverzeichnis |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |u https://swbplus.bsz-bw.de/bsz392312670cov.jpg |m V:DE-576 |m X:springer |q image/jpeg |v 20140212094334 |3 Cover |
| 935 | |i Blocktest | ||
| 936 | r | v | |a VS 8750 |b Allgemeines |k Chemie und Pharmazie |k Pharmazeutische Chemie und Molekularpharmakologie |k Einzelne Arzneimittel- und Wirkstoffgruppen |k Viruzid (Antiviraler Wirkstoff) |k Allgemeines |0 (DE-627)1271941678 |0 (DE-625)rvk/147721:253 |0 (DE-576)201941678 |
| 936 | b | k | |a 44.75 |j Infektionskrankheiten |j parasitäre Krankheiten |x Medizin |0 (DE-627)106415948 |
| 936 | b | k | |a 44.38 |j Pharmakologie |0 (DE-627)106409743 |
| 951 | |a BO | ||
| 990 | |a Viruzid | ||
| 990 | |a Molekularbiologie | ||
| 990 | |a Medizin | ||
| 990 | |a Viren | ||
| 992 | |a 20150722 | ||
| 999 | |a KXP-PPN75626426X |e 3106632798 | ||
| BIB | |a Y | ||
| SPR | |a Y | ||
| JSO | |a {"type":{"bibl":"edited-book"},"note":["Literaturangaben"],"physDesc":[{"extent":"XIV, 452 S.","noteIll":"Ill., graph. Darst."}],"recId":"75626426X","language":["eng"],"relMultPart":[{"id":{"issn":["1064-3745"],"eki":["131029002"],"zdb":["1095346-2"]},"origin":[{"publisherPlace":"New York, NY ; Heidelberg [u.a.] ; Clifton, NJ ; Totowa, NJ","dateIssuedDisp":"1984-","dateIssuedKey":"1984","publisher":"Humana Press ; Humana Press ; Humana Press"}],"dispAlt":"Methods in molecular biology","title":[{"title":"Methods in molecular biology","title_sort":"Methods in molecular biology"}],"part":{"number_sort":["1030"],"number":["1030"]},"titleAlt":[{"title":"MIMB"}],"pubHistory":["1.1984 -"],"recId":"131029002","language":["eng"],"disp":"Methods in molecular biology","type":{"bibl":"serial"}}],"name":{"displayForm":["edited by Edwin Yunhao Gong"]},"person":[{"role":"edt","display":"Gong, Edwin Yunhao","roleDisplay":"Hrsg.","given":"Edwin Yunhao","family":"Gong"}],"title":[{"title":"Antiviral methods and protocols","title_sort":"Antiviral methods and protocols"}],"origin":[{"publisher":"Humana Press","dateIssuedDisp":"c2013","dateIssuedKey":"2013","editionNo":"2","edition":"2. ed.","publisherPlace":"New York [u.a.]"}],"id":{"eki":["75626426X"],"isbn":["1627034838","9781627034838"]}} | ||
| SRT | |a ANTIVIRALM2013 | ||